Regulation of hepatic coenzyme Q biosynthesis by dietary omega-3 polyunsaturated fatty acids
In: Redox Biology, Jg. 46 (2021-10-01), S. 102061-102061
Online
unknown
Zugriff:
Dietary fats are important for human health, yet it is not fully understood how different fats affect various health problems. Although polyunsaturated fatty acids (PUFAs) are generally considered as highly oxidizable, those of the n-3 series can ameliorate the risk of many age-related disorders. Coenzyme Q (CoQ) is both an essential component of the mitochondrial electron transport chain and the only lipid-soluble antioxidant that animal cells can synthesize. Previous work has documented the protective antioxidant properties of CoQ against the autoxidation products of PUFAs. Here, we have explored in vitro and in vivo models to better understand the regulation of CoQ biosynthesis by dietary fats. In mouse liver, PUFAs increased CoQ content, and PUFAs of the n-3 series increased preferentially CoQ10. This response was recapitulated in hepatic cells cultured in the presence of lipid emulsions, where we additionally demonstrated a role for n-3 PUFAs as regulators of CoQ biosynthesis via the upregulation of several COQ proteins and farnesyl pyrophosphate levels. In both models, n-3 PUFAs altered the mitochondrial network without changing the overall mitochondrial mass. Furthermore, in cellular systems, n-3 PUFAs favored the synthesis of CoQ10 over CoQ9, thus altering the ratio between CoQ isoforms through a mechanism that involved downregulation of farnesyl diphosphate synthase activity. This effect was recapitulated by both siRNA silencing and by pharmacological inhibition of farnesyl diphosphate synthase with zoledronic acid. We highlight here the ability of n-3 PUFAs to regulate CoQ biosynthesis, CoQ content, and the ratio between its isoforms, which might be relevant to better understand the health benefits associated with this type of fat. Additionally, we identify for the first time zoledronic acid as a drug that inhibits CoQ biosynthesis, which must be also considered with respect to its biological effects on patients.
Graphical abstract Image 1
Highlights • Dietary fats exert differential actions on CoQ biosynthesis. • n-3 PUFAs increase CoQ biosynthesis and elevate hepatic CoQ content. • CoQ biosynthesis is influenced by COQ proteins expression and FPP content. • Farnesyldiphosphate synthase plays a key role in regulating the CoQ9/CoQ10 ratio. • Zoledronic acid is identified as a drug that inhibits CoQ biosynthesis.
Titel: |
Regulation of hepatic coenzyme Q biosynthesis by dietary omega-3 polyunsaturated fatty acids
|
---|---|
Autor/in / Beteiligte Person: | González-Reyes, José A. ; Burón, M. I. ; Villalba, José M. ; Gutiérrez-Casado, Elena ; Fernández-del-Río, Lucía ; Clarke, Catherine F. ; Rodríguez-López, Sandra |
Link: | |
Zeitschrift: | Redox Biology, Jg. 46 (2021-10-01), S. 102061-102061 |
Veröffentlichung: | Elsevier BV, 2021 |
Medientyp: | unknown |
ISSN: | 2213-2317 (print) |
DOI: | 10.1016/j.redox.2021.102061 |
Schlagwort: |
|
Sonstiges: |
|